Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Sarcoma 1Resectable Esophageal Cancer 1Pleural Mesothelial Neoplasm 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Hematologic Neoplasms 1Colorectal Neoplasms 1

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor 1Colony-Stimulating Factors 1Chemoradiotherapy 1Adjuvants, Immunologic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Resectable Esophageal Cancer × Adjuvants, Immunologic × 1 year × Clear all
NCT05307835 2025-12-02

Neoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical Resection

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 1 Active not recruiting
27 enrolled
Gastrointestinal

Resectable Esophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡